Lista de obras -

"Stealth" tumors: Breast cancer cells shun NK-cells anti-tumor immunity.

artículo científico publicado en 2012

A seven-gene prognostic model for platinum-treated ovarian carcinomas ⬇️

artículo científico publicado el 7 de junio de 2011

Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.

artículo científico publicado en 2017

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

artículo científico publicado en 2012

Are we turning to more than a first line treatment of metastatic colorectal cancer with high dose irinotecan?: A monocentric institution safety analysis of 46 patients.

artículo científico publicado en 2010

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival.

artículo científico publicado en 2016

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.

artículo científico publicado en 2017

Carcinomatous myelitis and meningitis after a squamous cell carcinoma of the lip.

artículo científico publicado en 2014

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

artículo científico publicado en 2014

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

artículo científico publicado en 2016

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

scientific article published on 08 June 2011

DNA microarrays and prediction of clinical outcome in ovarian carcinoma patients

artículo científico publicado en 2010

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

article

Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.

artículo científico publicado en 2011

Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancer

artículo científico publicado en 2011

Gene expression profiling and prediction of clinical outcome in ovarian cancer.

artículo científico publicado en 2009

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

artículo científico publicado en 2016

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

artículo científico publicado en 2017

Immune checkpoints inhibitors for solid tumours after allogeneic haematopoietic stem-cell transplantation: About four clinical cases

artículo científico publicado en 2017

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

artículo científico publicado en 2016

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.

artículo científico publicado en 2015

Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience

artículo científico publicado en 2017

Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.

artículo científico publicado en 2016

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease

scientific article published on 04 June 2019

Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature.

artículo científico publicado en 2010

METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors

artículo científico publicado en 2016

Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer

artículo científico publicado en 2018

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.

artículo científico publicado en 2016

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.

artículo científico publicado en 2017

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

artículo científico publicado en 2011

Personalized medicine: present and future of breast cancer management.

artículo científico

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.

artículo científico publicado en 2010

Prognostic and predictive value of PDL1 expression in breast cancer

artículo científico publicado en 2015

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.

artículo científico publicado en 2015

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

artículo científico publicado en 2016

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.

artículo científico publicado en 2017

Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer

artículo científico publicado en 2017

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

scientific article published on 06 May 2019

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study

scientific article published on 18 October 2016

Targeting Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

artículo científico publicado en 2018

The CINSARC signature: prognostic and predictive of response to chemotherapy?

artículo científico publicado en 2010

Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.

artículo científico publicado en 2017

[An "ariditary" form of ovarian cancer]

artículo científico publicado en 2010

[Circulating tumor DNA assessment for gynaecological cancers management]

scientific article published on 11 February 2019

[Pertuzumab (Perjeta®) approval in HER2-positive metastatic breast cancers].

artículo científico publicado en 2014

[Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers].

artículo científico publicado en 2015

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

artículo científico publicado en 2013

Lista de obras de

"Stealth" tumors: Breast cancer cells shun NK-cells anti-tumor immunity.

A seven-gene prognostic model for platinum-treated ovarian carcinomas ⬇️

Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

Are we turning to more than a first line treatment of metastatic colorectal cancer with high dose irinotecan?: A monocentric institution safety analysis of 46 patients.

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival.

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.

Carcinomatous myelitis and meningitis after a squamous cell carcinoma of the lip.

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

DNA microarrays and prediction of clinical outcome in ovarian carcinoma patients

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer

Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.

Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancer

Gene expression profiling and prediction of clinical outcome in ovarian cancer.

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Immune checkpoints inhibitors for solid tumours after allogeneic haematopoietic stem-cell transplantation: About four clinical cases

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.

Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience

Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.

Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease

Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature.

METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors

Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

Personalized medicine: present and future of breast cancer management.

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.

Prognostic and predictive value of PDL1 expression in breast cancer

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.

Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study

Targeting Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

The CINSARC signature: prognostic and predictive of response to chemotherapy?

Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.

[An "ariditary" form of ovarian cancer]

[Circulating tumor DNA assessment for gynaecological cancers management]

[Pertuzumab (Perjeta®) approval in HER2-positive metastatic breast cancers].

[Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers].

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].